-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Ayala Pharmaceuticals, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to 2023.
- Ayala Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$6.74M, a 32.5% increase year-over-year.
- Ayala Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$29.5M, a 14.6% increase from 2022.
- Ayala Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$34.5M, a 124% decline from 2021.
- Ayala Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$15.4M, a 29.6% increase from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)